HER2 Positive Breast Cancer

Tokyo, July 24, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products for...

NEW YORK, June 24, 2026 Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved IBRANCE®...

TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...